Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

Nivolumab Plus Ipilimumab (N+I) in Patients (pts) with Solid Tumors with High Tumor Mutational Burden (HTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.

John K. Chan,Michael Rothe,Pam K. Mangat,Elizabeth Garrett-Mayer,Timothy Lewis Cannon,Eugene R. Ahn,Paul Swiecicki,Evthokia Hobbs,Reza Nazemzadeh,Maria C. Bell,Peter Joel Hosein,Funda Meric-Bernstam,Dominique C. Hinshaw,Abby Gregory,Gina N. Grantham,Susan Halabi,Richard L. Schilsky

JOURNAL OF CLINICAL ONCOLOGY（2024）

Cited 0|Views0

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined